
PRENETICS LIMITED
Overview
Prenetics Global Limited (NASDAQ: PRE) is a Hong Kong-headquartered health sciences company founded in 2014 by CEO Danny Yeung. It focuses on consumer health, genomic testing, and precision oncology. Key brands include the fast-growing IM8 supplement brand, CircleDNA home testing, and ACT Genomics for cancer diagnostics, with operations in over 10 countries
Founded Year
2014
Ownership Type
Privately Held
Business Model
B2B (Business to Business)
Time Zone
Mission
Disrupt and Decentralize: To disrupt and decentralize the healthcare industry, bringing it closer to people.
Vision
Global Impact & Empowerment: To be a global health company that empowers everyone to be in control of their own health.
Core Values
Company Tagline
Head Office Country
China